The first over the counter Cove in nineteen antigen test approved by the FDA that could be used from start to finish at home will be coming toe Americans in January.

The test, created by the Australian company A Loom, offers a nasal swab analyzer that connects toe a free app on the user smartphone.

The APP walks the user step by step on how to use the test, and results are given in twenty minutes.

It costs about thirty dollars, and a doctor's note is not needed.

A Loom CEO Dr Sean Parsons.

So it's the first non prescription self test approved by the FDA for adults and Children to diagnose themselves with coronavirus SARS cov to whether they're symptomatic or asymptomatic.

So here's what the swab looks like.

It's not a big, long swab that goes all the way to tickle the base of your brain.

It's a swab of what's called your mid turbulent region, which is about that far back.

You then applied the swab to a small tube, which is supplied within the kit, and then you put the sample onto this analyzer, which you can see here, Dr Parsons said.

His tests will be going toe America first, that the biggest reason why it's going to America first is because it can make the biggest dent on helping Americans respond to coronavirus.

There are tens of thousands, hundreds of thousands of cases now today in the US, and these tests are most needed in America to assist the response.

The news follows authorization last month of the first prescription fully at Home Cove in nineteen test, and this week the FDA also blessed another at home rapid test, this one from Abbott Laboratories.

FDA Commissioner Stephen Hahn praised these developments, saying they will help expand Americans access to testing.

But the agency, however, cautioned that antigen tests like the one from a loom are less reliable than PCR tests and may have a small percentage of results that are false.